LAUREN LUSTIG: Open Payments
NPI 1770129991 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 33 payments from 13 companies in 2025. Trend: 2023 $546 · 2024 $849 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $154 |
| Lilly USA, LLC | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Novo Nordisk Inc | 4 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Alkermes, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, MOUNJARO, INGREZZA, JARDIANCE, ARISTADA, Cologuard Collection Kit, Veozah.
Industry payments across IL — which companies pay providers there.
